High-throughput sequencing in acute lymphoblastic leukemia: Follow-up of minimal residual disease and emergence of new clones - CRISTAL-BONSAI Accéder directement au contenu
Article Dans Une Revue Leukemia Research Année : 2017

High-throughput sequencing in acute lymphoblastic leukemia: Follow-up of minimal residual disease and emergence of new clones

Claude Preudhomme
  • Fonction : Auteur
  • PersonId : 899523

Résumé

Minimal residual disease (MRD) is known to be an independent prognostic factor in patients with acute lymphoblastic leukemia (ALL). High-throughput sequencing (HTS) is currently used in routine practice for the diagnosis and follow-up of patients with hematological neoplasms. In this retrospective study, we examined the role of immunoglobulin/T-cell receptor-based MRD in patients with ALL by HTS analysis of immunoglobulin H and/or T-cell receptor gamma chain loci in bone marrow samples from 11 patients with ALL, at diagnosis and during follow-up. We assessed the clinical feasibility of using combined HTS and bioinformatics analysis with interactive visualization using Vidjil software. We discuss the advantages and drawbacks of HTS for monitoring MRD. HTS gives a more complete insight of the leukemic population than conventional real-time quantitative PCR (qPCR), and allows identification of new emerging clones at each time point of the monitoring. Thus, HTS monitoring of Ig/TCR based MRD is expected to improve the management of patients with ALL.
Fichier principal
Vignette du fichier
2017-SalsonGiraudCaillaultGrardel-mrd-hal.pdf (727.42 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01404817 , version 1 (03-02-2018)

Identifiants

Citer

Mikael Salson, Mathieu Giraud, Aurélie Caillault, Nathalie Grardel, Nicolas Duployez, et al.. High-throughput sequencing in acute lymphoblastic leukemia: Follow-up of minimal residual disease and emergence of new clones. Leukemia Research, 2017, 53, pp.1-7. ⟨10.1016/j.leukres.2016.11.009⟩. ⟨hal-01404817⟩
323 Consultations
1735 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More